Investors who lost money on Novo Nordisk A/S (NVO) should contact The Gross Law Firm about pending Class Action - NVOGlobeNewsWire • 02/06/25
NVO DEADLINE APPROACHING: BFA Law Notifies Novo Nordisk Investors to Contact the Firm before the Upcoming March 25 Class Action Deadline (NYSE:NVO)GlobeNewsWire • 02/06/25
The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline - NVOPRNewsWire • 02/06/25
NVO DEADLINE NOTIFICATION: A Class Action Lawsuit was filed against Novo Nordisk -- Investors are Urged to Contact BFA Law before March 25 DeadlineAccesswire • 02/05/25
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugsCNBC • 02/05/25
NVO Q4 Earnings Beat Estimates, GLP-1 Drugs Boost Sales, Stock UpZacks Investment Research • 02/05/25
Novo Nordisk A/S Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Investors With Losses To Reach OutAccesswire • 02/05/25
Novo Nordisk Q4 Earnings: Outperformance Suggests Stock Price Comeback Starts TodaySeeking Alpha • 02/05/25
Amid Novo Nordisk's Win for Ozempic's Expanded Label to Include Chronic Kidney Disease Benefits, Spherix Global Insights Highlights Nephrologists' Rising Influence in GLP-1 RA UtilizationGlobeNewsWire • 02/05/25
Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026Benzinga • 02/05/25
Novo Nordisk says it's not immune to potential Trump tariffs, but business is well-positionedReuters • 02/05/25
Novo Nordisk reports strong Q4 profits but warns of slower growth in 2025Proactive Investors • 02/05/25